×
About 6,415 results

ALLMedicine™ Haemophilus Influenzae Center

Research & Reviews  1,447 results

Hexavalent vaccines: What can we learn from head-to-head studies?
https://doi.org/10.1016/j.vaccine.2021.08.086
Vaccine Knuf M, Haas H et. al.

Sep 18th, 2021 - Three hexavalent vaccines against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B virus (HBV), and Haemophilus influenzae type b (Hib) are licensed in Europe: Infanrix hexa (DT3aP-HBV-IPV/Hib), Hexyon (DT2aP-HBV-IPV-Hib) and Vaxelis (DT...

In Vitro Antibiotic Resistance among Bacteria from the Cornea in the Antibiotic Resista...
https://doi.org/10.1097/OPX.0000000000001768
Optometry and Vision Science : Official Publication of Th... Thomas RK, Melton R et. al.

Sep 13th, 2021 - This study aimed to report on in vitro susceptibility patterns among corneal isolates collected in the Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) study. Each year, from 2009 to 2019, Staphylococcus aureus, coagulase-negative...

Trend change of nasopharyngeal colonization with Streptococcus pneumoniae and nontypeab...
https://doi.org/10.1016/j.ijid.2021.08.065
International Journal of Infectious Diseases : IJID : Off... Choe YJ, Han MS et. al.

Sep 12th, 2021 - Nasopharyngeal (NP) colonization with Streptococcus pneumoniae and nontypeable Haemophilus influenzae (NTHi) is common in children and may evolve as the source of invasive infections. In Korea, the pneumococcal conjugate vaccines (PCVs) had been i...

Impact of Vaccination on Haemophilus influenzae Type b Carriage in Healthy Children Les...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409530
The Journal of Infectious Diseases; Shrestha S, Stockdale LK et. al.

Sep 2nd, 2021 - Reduction in detection of asymptomatic carriage of Haemophilus influenzae type b (Hib) can be used to assess vaccine impact. In Nepal, routine vaccination against Hib in children at 6, 10, and 14 weeks of age was introduced in 2009. Before vaccine...

The Role of Molecular Testing in Pediatric Meningitis Surveillance in Southern and East...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409535
The Journal of Infectious Diseases; du Plessis M, de Gouveia L et. al.

Sep 2nd, 2021 - As part of the global Invasive Bacterial Vaccine-Preventable Diseases Surveillance Network, 12 African countries referred cerebrospinal fluid (CSF) samples to South Africa's regional reference laboratory. We evaluated the utility of real-time poly...

see more →

Guidelines  4 results

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poli...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004397
MMWR. Morbidity and Mortality Weekly Report; Oliver SE, Moore KL

Feb 7th, 2020 - On December 21, 2018 the Food and Drug Administration (FDA) licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugate (meningo...

Prevention and control of meningococcal disease: recommendations of the Advisory Commit...
https://www.ncbi.nlm.nih.gov/pubmed/23515099
MMWR. Recommendations and Reports : Morbidity and Mortali... Cohn AC, MacNeil JR et. al.

Mar 22nd, 2013 - Meningococcal disease describes the spectrum of infections caused by Neisseria meningiditis, including meningitdis, bacteremia, and bacteremic pneumonia. Two quadrivalent meningococcal polysaccharide-protein conjugate vaccines that provide protect...

Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactiv...
https://www.ncbi.nlm.nih.gov/pubmed/18830213
MMWR. Morbidity and Mortality Weekly Report;

Oct 3rd, 2008 - On June 20, 2008 the Food and Drug Administration (FDA) licensed a combined diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP), inactivated poliovirus vaccine (IPV), and Haemophilus influenzae type b conjugate (tetanus toxoid [...

Laparoscopic splenectomy: the clinical practice guidelines of the European Association ...
https://doi.org/10.1007/s00464-007-9735-5
Surgical Endoscopy; Habermalz B, Sauerland S et. al.

Feb 23rd, 2008 - Although laparoscopic splenectomy (LS) has become the standard approach for most splenectomy cases, some areas still remain controversial. To date, the indications that preclude laparoscopic splenectomy are not clearly defined. In view of this, th...

see more →

Drugs  960 results see all →

News  154 results

High Antimicrobial Use Seen in COVID Patients During First Wave
https://www.medscape.com/viewarticle/952344

Jun 3rd, 2021 - Use of antimicrobials among COVID-19 patients should be assisted by clear guidelines to reduce the risk of drug-resistance, experts said. Patients had a median age of 74. The timing of infection was recorded either as occurring prior to hospitalis...

Short-Course Antibiotic Prescribing Clinical Practice Guidelines (ACP, 2021)
https://reference.medscape.com/viewarticle/950132

Apr 29th, 2021 - Guidelines on appropriate short-course antibiotics in common infections were published in April 2021 by the American College of Physicians in the Annals of Internal Medicine.[1,2] Chronic Obstructive Pulmonary Disease and Uncomplicated Bronchitis ...

Why is AOM frequency decreasing in the pneumococcal conjugate vaccine era?
https://www.mdedge.com/pediatrics/article/215368/infectious-diseases/why-aom-frequency-decreasing-pneumococcal-conjugate?channel=41022
Michael E. Pichichero, MD

Jan 10th, 2020 - In 2000, pneumococcal conjugate vaccine 7 (PCV7) was introduced in the United States, and in 2010, PCV13 was introduced. When each of those vaccines were used, they reduced acute otitis media (AOM) incidence caused by the pneumococcal types includ.

FDA OKs First-in-Class Antibiotic Lefamulin (Xenleta) for CABP
https://www.medscape.com/viewarticle/917020

Aug 19th, 2019 - The US Food and Drug Administration (FDA) has approved lefamulin (Xenleta, Nabriva Theraputics), a new oral and intravenous (IV) antibiotic for the treatment of adults with community-acquired bacterial pneumonia (CABP). Lefamulin is a first-in-cla...

FDA OKs First-in-Class Antibiotic Lefamulin (Xenleta) for CABP
https://www.staging.medscape.com/viewarticle/917020

Aug 19th, 2019 - The US Food and Drug Administration (FDA) has approved lefamulin (Xenleta, Nabriva Theraputics), a new oral and intravenous (IV) antibiotic for the treatment of adults with community-acquired bacterial pneumonia (CABP). Lefamulin is a first-in-cla...

see more →

Patient Education  1 results see all →